Cite

HARVARD Citation

    Yuan, Y. et al. (2021). Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer. Oncologist. pp. e382-e393. [Online]. 
  
Back to record